Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults
Sponsor: Addpharma Inc.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-234, AD-2341, AD-2342 in healthy subjects.
Official title: A Randomized, Open-label, 6-sequence, 3-period Crossover Clinical Trial to Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adult Volunteers.
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-08
Completion Date
2026-11
Last Updated
2026-07-27
Healthy Volunteers
Yes
Conditions
Interventions
AD-234
AD-234 tablet administered orally
AD-2341
AD-2341 tablet administered orally
AD-2342
AD-2342 tablet administered orally
Locations (1)
Seoul National University Hospital, Seoul,
Seoul, South Korea